Abigail Calder
Diploma Assistant / PhD student at the University of Fribourg
Data updated
Research Footprint
Abigail Calder appears in 6 tracked papers (2022–2026), most studied alongside LSD, Psilocybin and Ayahuasca, across Depressive Disorders, Healthy Volunteers and Neuroimaging & Brain Measures.
Most-cited paper: Towards an understanding of psychedelic-induced neuroplasticity (294 citations).
Frequent co-authors: Gregor Hasler, Andreas Eckert and Matthias Liechti.
Background & Research
Abigail E. Calder is a researcher at the University of Fribourg in Switzerland. According to her university profile, she joined the group as a PhD student in January 2021 after completing a master’s degree in neuroscience at the University of Bonn, and her work focuses on the effects of LSD in healthy subjects and drug-induced changes in cortical neuroplasticity. Her published and publicly discussed work includes studies on psychedelic-induced neuroplasticity, microdosing safety, side-effect measurement, and antidepressant response in psychedelic therapy.
Key Impact
She is a psychedelic researcher whose work spans neuroplasticity, safety, adverse effects, and clinical outcomes in psychedelic-assisted therapy.
Collaboration Network
18 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Abigail Calder is associated with.